BENO Holding AG (BENH) - Net Assets
Based on the latest financial reports, BENO Holding AG (BENH) has net assets worth €- EUR (≈ $- USD) as of . Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€- ≈ $- USD) and total liabilities (€- ≈ $- USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See how leveraged is BENO Holding AG's balance sheet to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | 13.37% |
| 5-Year Change | 95.16% |
| 10-Year Change | N/A |
| Growth Volatility | 9.13 |
BENO Holding AG - Net Assets Trend (2019–2025)
This chart illustrates how BENO Holding AG's net assets have evolved over time, based on quarterly financial data. Also explore BENO Holding AG (BENH) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Net Assets for BENO Holding AG (2019–2025)
The table below shows the annual net assets of BENO Holding AG from 2019 to 2025. For live market cap and overall valuation, see market cap of BENO Holding AG.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €34.93 Million ≈ $40.84 Million |
+16.11% |
| 2024-12-31 | €30.09 Million ≈ $35.18 Million |
+15.95% |
| 2023-12-31 | €25.95 Million ≈ $30.34 Million |
+25.62% |
| 2022-12-31 | €20.66 Million ≈ $24.15 Million |
+15.41% |
| 2021-12-31 | €17.90 Million ≈ $20.93 Million |
+14.34% |
| 2020-12-31 | €15.65 Million ≈ $18.30 Million |
-4.85% |
| 2019-12-31 | €16.45 Million ≈ $19.24 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to BENO Holding AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €34.93 Million | 100.00% |
| Total Equity | €34.93 Million | 100.00% |
BENO Holding AG Competitors by Market Cap
The table below lists competitors of BENO Holding AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Thor Mining PLC
LSE:THR
|
$68.93K |
|
Autins Group plc
LSE:AUTG
|
$69.76K |
|
Cizzle Biotechnology Holdings PLC
LSE:CIZ
|
$69.93K |
|
Walker Crips Group PLC
LSE:WCW
|
$69.94K |
|
Vincerx Pharma, Inc. Common Stock
NASDAQ:VINC
|
$68.05K |
|
World Chess PLC
LSE:CHSS
|
$67.52K |
|
Kasikornbank Public Company Limited
F:TFBF
|
$67.48K |
|
Touchstar plc
LSE:TST
|
$67.47K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BENO Holding AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 30,088,000 to 34,934,000, a change of 4,846,000 (16.1%).
- Net income of 4,745,000 contributed positively to equity growth.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €4.75 Million | +13.58% |
| Other Changes | €101.00K | +0.29% |
| Total Change | €- | 16.11% |
Book Value vs Market Value Analysis
This analysis compares BENO Holding AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.61x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.17x to 0.61x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | €5.33 | €6.25 | x |
| 2020-12-31 | €5.07 | €6.25 | x |
| 2021-12-31 | €5.29 | €6.25 | x |
| 2022-12-31 | €6.10 | €6.25 | x |
| 2023-12-31 | €7.66 | €6.25 | x |
| 2024-12-31 | €8.88 | €6.25 | x |
| 2025-12-31 | €10.31 | €6.25 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BENO Holding AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.58%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 51.55%
- • Asset Turnover: 0.09x
- • Equity Multiplier: 2.85x
- Recent ROE (13.58%) is above the historical average (11.69%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 13.33% | 33.09% | 0.11x | 3.75x | €548.70K |
| 2020 | -5.10% | -11.26% | 0.11x | 4.23x | €-2.36 Million |
| 2021 | 11.84% | 29.04% | 0.09x | 4.52x | €329.00K |
| 2022 | 13.94% | 32.25% | 0.10x | 4.37x | €814.20K |
| 2023 | 20.74% | 55.49% | 0.10x | 3.63x | €2.79 Million |
| 2024 | 13.51% | 46.57% | 0.09x | 3.23x | €1.06 Million |
| 2025 | 13.58% | 51.55% | 0.09x | 2.85x | €1.25 Million |
Industry Comparison
This section compares BENO Holding AG's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BENO Holding AG (BENH) | €- | 13.33% | N/A | $68.16K |
| Covestro AG (1COV) | $4.22 Billion | 18.86% | 1.43x | $11.10 Billion |
| CENTESSA PHARMACEUTICALS (260) | $491.55 Million | 0.00% | 0.28x | $5.35 Billion |
| 2invest AG (2INV) | $48.10 Million | -5.52% | 0.29x | $70.69 Million |
| COINSHARES I. LS-000247 (3TW) | $269.95 Million | -1206.08% | 19.01x | $472.53 Million |
| Adaptimmune Therapeutics plc (473A) | $81.88 Million | -202.08% | 3.02x | $42.94 Million |
| KINGMAN MINERALS LTD. (47A) | $1.72 Million | -14.34% | 0.35x | $141.89K |
| GENOR BIOPHARMA DL-00002 (67N0) | $1.15 Billion | -4.45% | 0.12x | $93.97 Million |
| Biotest Aktiengesellschaft (BIO) | $103.29 Million | -5.08% | 2.39x | $976.15 Million |
| Biotest Aktiengesellschaft (BIO3) | $476.90 Million | -0.99% | 1.32x | $656.94 Million |
About BENO Holding AG
BENO Holding AG, through its subsidiaries, engages in the rental of real estate properties for medium-sized companies in Germany. The company creates digital twins light industrial properties, improve collaborative processes, save time, and reduce CO2 emissions; and provides professional asset management services. BENO Holding AG was incorporated in 2014 and is based in Munich, Germany.